SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009999
Filing Date
2019-11-05
Accepted
2019-11-05 17:06:54
Documents
61
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20190930x10q56b858.htm   iXBRL 10-Q 1806128
2 EX-10.1 ex-10d1.htm EX-10.1 16252
3 EX-31.1 ex-31d1.htm EX-31.1 19367
4 EX-31.2 ex-31d2.htm EX-31.2 19383
5 EX-32.1 ex-32d1.htm EX-32.1 10577
  Complete submission text file 0001558370-19-009999.txt   7658880

Data Files

Seq Description Document Type Size
6 EX-101.SCH xncr-20190930.xsd EX-101.SCH 42295
7 EX-101.CAL xncr-20190930_cal.xml EX-101.CAL 53640
8 EX-101.DEF xncr-20190930_def.xml EX-101.DEF 179099
9 EX-101.LAB xncr-20190930_lab.xml EX-101.LAB 463316
10 EX-101.PRE xncr-20190930_pre.xml EX-101.PRE 340509
57 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20190930x10q56b858_htm.xml XML 1610392
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 191194197
SIC: 2834 Pharmaceutical Preparations